The global pet diabetes care devices market was valued at $1.9 billion in 2021, and is projected to reach $3.5 billion by 2031, growing at a CAGR of 6.3% from 2022 to 2031.
Diabetes mellitus, or diabetes, is a condition that occurs when the body cannot use glucose normally. Glucose is the main source of energy for the body’s cells. Pets such as dogs, cats and also livestock suffer from diabetes too. Obesity is a significant risk factor for development of diabetes in pets, they may also develop other diseases that can result in diabetes or can significantly affect their response to treatment for diabetes, including over activity of the adrenal gland in dogs or hyperthyroidism in cats, pancreatitis, heart disease, kidney disease, urinary tract infections and skin infections. To treat this condition in pets, there are device segments available in the market that are bifurcated into glucose monitoring devices and insulin delivery devices.
The growth of the pet diabetes care devices market is driven by factors such as increase in incidence of diabetes, increase in demand for diabetes monitoring devices in the veterinary hospitals and increase in the technological advancements of the pet diabetes care devices. Moreover, increase in the adoption of pets for several benefits of the humans, rise in cases of pet obesity across the globe, favorable government support for animal type healthcare, growth in awareness about veterinary healthcare importance among the pet owners, rise in animal healthcare expenditure and increase in the number of hospitals & animal healthcare centers also helps in the growth of the market. For instance, according to the data of American Pet Products Association (APPA), in 2019, the pet expenditure reached $95.7 billion in 2019, which was a 5% increase than 2018. This outlay covers pet food, treats, over-the-counter medicine, vet care, animal type health products and other services (include boarding, grooming, insurance, training, pet sitting and walking). However, the limited awareness surrounding proper management of pet diabetes is expected to hinder the growth of this market. Conversely, increased research initiatives on pet diabetes is expected to create lucrative opportunities for the market.
The global pet diabetes care devices market is segmented on the basis of device type, animal type, end user and region. On the basis of device type, the market is bifurcated into glucose monitoring devices and insulin delivery devices. On the basis of animal type, the market is classified into dogs and cats. On the basis of end user, the market is classified into homecare, veterinary hospitals and others. Region wise, the market is studied across North America (the U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Major companies profiled in the report include AccuBioTech Co., Ltd., Allison Medical Inc., ALR Technologies Inc., Becton, Dickinson and Company, MED Trust, Merck Animal Health, TaiDoc, UltiMed, Inc., Zoetis, i-SENS, Inc.
Diabetes mellitus, or diabetes, is a condition that occurs when the body cannot use glucose normally. Glucose is the main source of energy for the body’s cells. Pets such as dogs, cats and also livestock suffer from diabetes too. Obesity is a significant risk factor for development of diabetes in pets, they may also develop other diseases that can result in diabetes or can significantly affect their response to treatment for diabetes, including over activity of the adrenal gland in dogs or hyperthyroidism in cats, pancreatitis, heart disease, kidney disease, urinary tract infections and skin infections. To treat this condition in pets, there are device segments available in the market that are bifurcated into glucose monitoring devices and insulin delivery devices.
The growth of the pet diabetes care devices market is driven by factors such as increase in incidence of diabetes, increase in demand for diabetes monitoring devices in the veterinary hospitals and increase in the technological advancements of the pet diabetes care devices. Moreover, increase in the adoption of pets for several benefits of the humans, rise in cases of pet obesity across the globe, favorable government support for animal type healthcare, growth in awareness about veterinary healthcare importance among the pet owners, rise in animal healthcare expenditure and increase in the number of hospitals & animal healthcare centers also helps in the growth of the market. For instance, according to the data of American Pet Products Association (APPA), in 2019, the pet expenditure reached $95.7 billion in 2019, which was a 5% increase than 2018. This outlay covers pet food, treats, over-the-counter medicine, vet care, animal type health products and other services (include boarding, grooming, insurance, training, pet sitting and walking). However, the limited awareness surrounding proper management of pet diabetes is expected to hinder the growth of this market. Conversely, increased research initiatives on pet diabetes is expected to create lucrative opportunities for the market.
The global pet diabetes care devices market is segmented on the basis of device type, animal type, end user and region. On the basis of device type, the market is bifurcated into glucose monitoring devices and insulin delivery devices. On the basis of animal type, the market is classified into dogs and cats. On the basis of end user, the market is classified into homecare, veterinary hospitals and others. Region wise, the market is studied across North America (the U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Major companies profiled in the report include AccuBioTech Co., Ltd., Allison Medical Inc., ALR Technologies Inc., Becton, Dickinson and Company, MED Trust, Merck Animal Health, TaiDoc, UltiMed, Inc., Zoetis, i-SENS, Inc.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the pet diabetes care devices market analysis from 2021 to 2031 to identify the prevailing pet diabetes care devices market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the pet diabetes care devices market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global pet diabetes care devices market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Animal Type
- Dogs
- Cats
By End Users
- Homecare
- Veterinary hospitals
- Others
By Device Type
- Glucose monitoring devices
- Insulin delivery devices
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- Allison Medical Inc.
- ALR Technologies Inc.
- Med Trust LLC
- Zoetis
- AccuBioTech Co., Ltd.
- Merck & Co. Inc.
- Becton, Dickinson and Company
- Taidoc Technology Corp.
- UltiMed, Inc
- I-SENS. Inc.
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in the number of pet adoption.
3.4.1.2. Rise in the prevalence of diabetes in pets.
3.4.1.3. Rise in the pet obesity.
3.4.1.4. Increase in the research and development activity related to the treatment of diabetes.
3.4.2. Restraints
3.4.2.1. High cost of diabetic medications.
3.4.3. Opportunities
3.4.3.1. Technological advancements in the diabetes care devices.
3.5. COVID-19 Impact Analysis on the market
CHAPTER 4: PET DIABETES CARE DEVICES MARKET, BY DEVICE TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2. Glucose monitoring devices
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market share analysis by country
4.3. Insulin delivery devices
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market share analysis by country
CHAPTER 5: PET DIABETES CARE DEVICES MARKET, BY ANIMAL TYPE
5.1 Overview
5.1.1 Market size and forecast
5.2. Dogs
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market share analysis by country
5.3. Cats
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market share analysis by country
CHAPTER 6: PET DIABETES CARE DEVICES MARKET, BY END USERS
6.1 Overview
6.1.1 Market size and forecast
6.2. Homecare
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market share analysis by country
6.3. Veterinary hospitals
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market share analysis by country
6.4. Others
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market share analysis by country
CHAPTER 7: PET DIABETES CARE DEVICES MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Device Type
7.2.3 North America Market size and forecast, by Animal Type
7.2.4 North America Market size and forecast, by End Users
7.2.5 North America Market size and forecast, by country
7.2.5.1 U.S.
7.2.5.1.1 Key market trends, growth factors and opportunities
7.2.5.1.2 Market size and forecast, by Device Type
7.2.5.1.3 Market size and forecast, by Animal Type
7.2.5.1.4 Market size and forecast, by End Users
7.2.5.2 Canada
7.2.5.2.1 Key market trends, growth factors and opportunities
7.2.5.2.2 Market size and forecast, by Device Type
7.2.5.2.3 Market size and forecast, by Animal Type
7.2.5.2.4 Market size and forecast, by End Users
7.2.5.3 Mexico
7.2.5.3.1 Key market trends, growth factors and opportunities
7.2.5.3.2 Market size and forecast, by Device Type
7.2.5.3.3 Market size and forecast, by Animal Type
7.2.5.3.4 Market size and forecast, by End Users
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Device Type
7.3.3 Europe Market size and forecast, by Animal Type
7.3.4 Europe Market size and forecast, by End Users
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Key market trends, growth factors and opportunities
7.3.5.1.2 Market size and forecast, by Device Type
7.3.5.1.3 Market size and forecast, by Animal Type
7.3.5.1.4 Market size and forecast, by End Users
7.3.5.2 France
7.3.5.2.1 Key market trends, growth factors and opportunities
7.3.5.2.2 Market size and forecast, by Device Type
7.3.5.2.3 Market size and forecast, by Animal Type
7.3.5.2.4 Market size and forecast, by End Users
7.3.5.3 UK
7.3.5.3.1 Key market trends, growth factors and opportunities
7.3.5.3.2 Market size and forecast, by Device Type
7.3.5.3.3 Market size and forecast, by Animal Type
7.3.5.3.4 Market size and forecast, by End Users
7.3.5.4 Italy
7.3.5.4.1 Key market trends, growth factors and opportunities
7.3.5.4.2 Market size and forecast, by Device Type
7.3.5.4.3 Market size and forecast, by Animal Type
7.3.5.4.4 Market size and forecast, by End Users
7.3.5.5 Spain
7.3.5.5.1 Key market trends, growth factors and opportunities
7.3.5.5.2 Market size and forecast, by Device Type
7.3.5.5.3 Market size and forecast, by Animal Type
7.3.5.5.4 Market size and forecast, by End Users
7.3.5.6 Rest of Europe
7.3.5.6.1 Key market trends, growth factors and opportunities
7.3.5.6.2 Market size and forecast, by Device Type
7.3.5.6.3 Market size and forecast, by Animal Type
7.3.5.6.4 Market size and forecast, by End Users
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Device Type
7.4.3 Asia-Pacific Market size and forecast, by Animal Type
7.4.4 Asia-Pacific Market size and forecast, by End Users
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 China
7.4.5.1.1 Key market trends, growth factors and opportunities
7.4.5.1.2 Market size and forecast, by Device Type
7.4.5.1.3 Market size and forecast, by Animal Type
7.4.5.1.4 Market size and forecast, by End Users
7.4.5.2 Japan
7.4.5.2.1 Key market trends, growth factors and opportunities
7.4.5.2.2 Market size and forecast, by Device Type
7.4.5.2.3 Market size and forecast, by Animal Type
7.4.5.2.4 Market size and forecast, by End Users
7.4.5.3 India
7.4.5.3.1 Key market trends, growth factors and opportunities
7.4.5.3.2 Market size and forecast, by Device Type
7.4.5.3.3 Market size and forecast, by Animal Type
7.4.5.3.4 Market size and forecast, by End Users
7.4.5.4 Australia
7.4.5.4.1 Key market trends, growth factors and opportunities
7.4.5.4.2 Market size and forecast, by Device Type
7.4.5.4.3 Market size and forecast, by Animal Type
7.4.5.4.4 Market size and forecast, by End Users
7.4.5.5 South Korea
7.4.5.5.1 Key market trends, growth factors and opportunities
7.4.5.5.2 Market size and forecast, by Device Type
7.4.5.5.3 Market size and forecast, by Animal Type
7.4.5.5.4 Market size and forecast, by End Users
7.4.5.6 Rest of Asia-Pacific
7.4.5.6.1 Key market trends, growth factors and opportunities
7.4.5.6.2 Market size and forecast, by Device Type
7.4.5.6.3 Market size and forecast, by Animal Type
7.4.5.6.4 Market size and forecast, by End Users
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Device Type
7.5.3 LAMEA Market size and forecast, by Animal Type
7.5.4 LAMEA Market size and forecast, by End Users
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Key market trends, growth factors and opportunities
7.5.5.1.2 Market size and forecast, by Device Type
7.5.5.1.3 Market size and forecast, by Animal Type
7.5.5.1.4 Market size and forecast, by End Users
7.5.5.2 Saudi Arabia
7.5.5.2.1 Key market trends, growth factors and opportunities
7.5.5.2.2 Market size and forecast, by Device Type
7.5.5.2.3 Market size and forecast, by Animal Type
7.5.5.2.4 Market size and forecast, by End Users
7.5.5.3 South Africa
7.5.5.3.1 Key market trends, growth factors and opportunities
7.5.5.3.2 Market size and forecast, by Device Type
7.5.5.3.3 Market size and forecast, by Animal Type
7.5.5.3.4 Market size and forecast, by End Users
7.5.5.4 Rest of LAMEA
7.5.5.4.1 Key market trends, growth factors and opportunities
7.5.5.4.2 Market size and forecast, by Device Type
7.5.5.4.3 Market size and forecast, by Animal Type
7.5.5.4.4 Market size and forecast, by End Users
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top player positioning, 2021
CHAPTER 9: COMPANY PROFILES
9.1 Allison Medical Inc.
9.1.1 Company overview
9.1.2 Key Executives
9.1.3 Company snapshot
9.1.4 Operating business segments
9.1.5 Product portfolio
9.1.6 Business performance
9.1.7 Key strategic moves and developments
9.2 ALR Technologies Inc.
9.2.1 Company overview
9.2.2 Key Executives
9.2.3 Company snapshot
9.2.4 Operating business segments
9.2.5 Product portfolio
9.2.6 Business performance
9.2.7 Key strategic moves and developments
9.3 Med Trust LLC
9.3.1 Company overview
9.3.2 Key Executives
9.3.3 Company snapshot
9.3.4 Operating business segments
9.3.5 Product portfolio
9.3.6 Business performance
9.3.7 Key strategic moves and developments
9.4 Zoetis
9.4.1 Company overview
9.4.2 Key Executives
9.4.3 Company snapshot
9.4.4 Operating business segments
9.4.5 Product portfolio
9.4.6 Business performance
9.4.7 Key strategic moves and developments
9.5 AccuBioTech Co., Ltd.
9.5.1 Company overview
9.5.2 Key Executives
9.5.3 Company snapshot
9.5.4 Operating business segments
9.5.5 Product portfolio
9.5.6 Business performance
9.5.7 Key strategic moves and developments
9.6 Merck & Co. Inc.
9.6.1 Company overview
9.6.2 Key Executives
9.6.3 Company snapshot
9.6.4 Operating business segments
9.6.5 Product portfolio
9.6.6 Business performance
9.6.7 Key strategic moves and developments
9.7 Becton, Dickinson and Company
9.7.1 Company overview
9.7.2 Key Executives
9.7.3 Company snapshot
9.7.4 Operating business segments
9.7.5 Product portfolio
9.7.6 Business performance
9.7.7 Key strategic moves and developments
9.8 Taidoc Technology Corp.
9.8.1 Company overview
9.8.2 Key Executives
9.8.3 Company snapshot
9.8.4 Operating business segments
9.8.5 Product portfolio
9.8.6 Business performance
9.8.7 Key strategic moves and developments
9.9 UltiMed, Inc
9.9.1 Company overview
9.9.2 Key Executives
9.9.3 Company snapshot
9.9.4 Operating business segments
9.9.5 Product portfolio
9.9.6 Business performance
9.9.7 Key strategic moves and developments
9.10 I-SENS. Inc.
9.10.1 Company overview
9.10.2 Key Executives
9.10.3 Company snapshot
9.10.4 Operating business segments
9.10.5 Product portfolio
9.10.6 Business performance
9.10.7 Key strategic moves and developments
List of Tables
Table 1. Global Pet Diabetes Care Devices Market, by Device Type, 2021-2031 (Revenue, $Million)
Table 2. Pet Diabetes Care Devices Market for Glucose Monitoring Devices, by Region, 2021-2031 (Revenue, $Million)
Table 3. Pet Diabetes Care Devices Market for Insulin Delivery Devices, by Region, 2021-2031 (Revenue, $Million)
Table 4. Global Pet Diabetes Care Devices Market, by Animal Type, 2021-2031 (Revenue, $Million)
Table 5. Pet Diabetes Care Devices Market for Dogs, by Region, 2021-2031 (Revenue, $Million)
Table 6. Pet Diabetes Care Devices Market for Cats, by Region, 2021-2031 (Revenue, $Million)
Table 7. Global Pet Diabetes Care Devices Market, by End-users, 2021-2031 (Revenue, $Million)
Table 8. Pet Diabetes Care Devices Market for Homecare, by Region, 2021-2031 (Revenue, $Million)
Table 9. Pet Diabetes Care Devices Market for Veterinary Hospitals, by Region, 2021-2031 (Revenue, $Million)
Table 10. Pet Diabetes Care Devices Market for Others, by Region, 2021-2031 (Revenue, $Million)
Table 11. Pet Diabetes Care Devices Market, by Region, 2021-2031 (Revenue, $Million)
Table 12. North America Pet Diabetes Care Devices Market, by Device Type, 2021-2031 (Revenue, $Million)
Table 13. North America Pet Diabetes Care Devices Market, by Animal Type, 2021-2031 (Revenue, $Million)
Table 14. North America Pet Diabetes Care Devices Market, by End-users, 2021-2031 (Revenue, $Million)
Table 15. North America Pet Diabetes Care Devices Market, by Country, 2021-2031 (Revenue, $Million)
Table 16. U.S. Pet Diabetes Care Devices Market, by Device Type, 2021-2031 (Revenue, $Million)
Table 17. U.S. Pet Diabetes Care Devices Market, by Animal Type, 2021-2031 (Revenue, $Million)
Table 18. U.S. Pet Diabetes Care Devices Market, by End-users, 2021-2031 (Revenue, $Million)
Table 19. Canada Pet Diabetes Care Devices Market, by Device Type, 2021-2031 (Revenue, $Million)
Table 20. Canada Pet Diabetes Care Devices Market, by Animal Type, 2021-2031 (Revenue, $Million)
Table 21. Canada Pet Diabetes Care Devices Market, by End-users, 2021-2031 (Revenue, $Million)
Table 22. Mexico Pet Diabetes Care Devices Market, by Device Type, 2021-2031 (Revenue, $Million)
Table 23. Mexico Pet Diabetes Care Devices Market, by Animal Type, 2021-2031 (Revenue, $Million)
Table 24. Mexico Pet Diabetes Care Devices Market, by End-users, 2021-2031 (Revenue, $Million)
Table 25. Europe Pet Diabetes Care Devices Market, by Device Type, 2021-2031 (Revenue, $Million)
Table 26. Europe Pet Diabetes Care Devices Market, by Animal Type, 2021-2031 (Revenue, $Million)
Table 27. Europe Pet Diabetes Care Devices Market, by End-users, 2021-2031 (Revenue, $Million)
Table 28. Europe Pet Diabetes Care Devices Market, by Country, 2021-2031 (Revenue, $Million)
Table 29. Germany Pet Diabetes Care Devices Market, by Device Type, 2021-2031 (Revenue, $Million)
Table 30. Germany Pet Diabetes Care Devices Market, by Animal Type, 2021-2031 (Revenue, $Million)
Table 31. Germany Pet Diabetes Care Devices Market, by End-users, 2021-2031 (Revenue, $Million)
Table 32. France Pet Diabetes Care Devices Market, by Device Type, 2021-2031 (Revenue, $Million)
Table 33. France Pet Diabetes Care Devices Market, by Animal Type, 2021-2031 (Revenue, $Million)
Table 34. France Pet Diabetes Care Devices Market, by End-users, 2021-2031 (Revenue, $Million)
Table 35. UK Pet Diabetes Care Devices Market, by Device Type, 2021-2031 (Revenue, $Million)
Table 36. UK Pet Diabetes Care Devices Market, by Animal Type, 2021-2031 (Revenue, $Million)
Table 37. UK Pet Diabetes Care Devices Market, by End-users, 2021-2031 (Revenue, $Million)
Table 38. Italy Pet Diabetes Care Devices Market, by Device Type, 2021-2031 (Revenue, $Million)
Table 39. Italy Pet Diabetes Care Devices Market, by Animal Type, 2021-2031 (Revenue, $Million)
Table 40. Italy Pet Diabetes Care Devices Market, by End-users, 2021-2031 (Revenue, $Million)
Table 41. Spain Pet Diabetes Care Devices Market, by Device Type, 2021-2031 (Revenue, $Million)
Table 42. Spain Pet Diabetes Care Devices Market, by Animal Type, 2021-2031 (Revenue, $Million)
Table 43. Spain Pet Diabetes Care Devices Market, by End-users, 2021-2031 (Revenue, $Million)
Table 44. Rest of Europe Pet Diabetes Care Devices Market, by Device Type, 2021-2031 (Revenue, $Million)
Table 45. Rest of Europe Pet Diabetes Care Devices Market, by Animal Type, 2021-2031 (Revenue, $Million)
Table 46. Rest of Europe Pet Diabetes Care Devices Market, by End-users, 2021-2031 (Revenue, $Million)
Table 47. Asia-Pacific Pet Diabetes Care Devices Market, by Device Type, 2021-2031 (Revenue, $Million)
Table 48. Asia-Pacific Pet Diabetes Care Devices Market, by Animal Type, 2021-2031 (Revenue, $Million)
Table 49. Asia-Pacific Pet Diabetes Care Devices Market, by End-users, 2021-2031 (Revenue, $Million)
Table 50. Asia-Pacific Pet Diabetes Care Devices Market, by Country, 2021-2031 (Revenue, $Million)
Table 51. China Pet Diabetes Care Devices Market, by Device Type, 2021-2031 (Revenue, $Million)
Table 52. China Pet Diabetes Care Devices Market, by Animal Type, 2021-2031 (Revenue, $Million)
Table 53. China Pet Diabetes Care Devices Market, by End-users, 2021-2031 (Revenue, $Million)
Table 54. Japan Pet Diabetes Care Devices Market, by Device Type, 2021-2031 (Revenue, $Million)
Table 55. Japan Pet Diabetes Care Devices Market, by Animal Type, 2021-2031 (Revenue, $Million)
Table 56. Japan Pet Diabetes Care Devices Market, by End-users, 2021-2031 (Revenue, $Million)
Table 57. India Pet Diabetes Care Devices Market, by Device Type, 2021-2031 (Revenue, $Million)
Table 58. India Pet Diabetes Care Devices Market, by Animal Type, 2021-2031 (Revenue, $Million)
Table 59. India Pet Diabetes Care Devices Market, by End-users, 2021-2031 (Revenue, $Million)
Table 60. Australia Pet Diabetes Care Devices Market, by Device Type, 2021-2031 (Revenue, $Million)
Table 61. Australia Pet Diabetes Care Devices Market, by Animal Type, 2021-2031 (Revenue, $Million)
Table 62. Australia Pet Diabetes Care Devices Market, by End-users, 2021-2031 (Revenue, $Million)
Table 63. South Korea Pet Diabetes Care Devices Market, by Device Type, 2021-2031 (Revenue, $Million)
Table 64. South Korea Pet Diabetes Care Devices Market, by Animal Type, 2021-2031 (Revenue, $Million)
Table 65. South Korea Pet Diabetes Care Devices Market, by End-users, 2021-2031 (Revenue, $Million)
Table 66. Rest of Asia-Pacific Pet Diabetes Care Devices Market, by Device Type, 2021-2031 (Revenue, $Million)
Table 67. Rest of Asia-Pacific Pet Diabetes Care Devices Market, by Animal Type, 2021-2031 (Revenue, $Million)
Table 68. Rest of Asia-Pacific Pet Diabetes Care Devices Market, by End-users, 2021-2031 (Revenue, $Million)
Table 69. LAMEA Pet Diabetes Care Devices Market, by Device Type, 2021-2031 (Revenue, $Million)
Table 70. LAMEA Pet Diabetes Care Devices Market, by Animal Type, 2021-2031 (Revenue, $Million)
Table 71. LAMEA Pet Diabetes Care Devices Market, by End-users, 2021-2031 (Revenue, $Million)
Table 72. LAMEA Pet Diabetes Care Devices Market, by Country, 2021-2031 (Revenue, $Million)
Table 73. Brazil Pet Diabetes Care Devices Market, by Device Type, 2021-2031 (Revenue, $Million)
Table 74. Brazil Pet Diabetes Care Devices Market, by Animal Type, 2021-2031 (Revenue, $Million)
Table 75. Brazil Pet Diabetes Care Devices Market, by End-users, 2021-2031 (Revenue, $Million)
Table 76. Saudi Arabia Pet Diabetes Care Devices Market, by Device Type, 2021-2031 (Revenue, $Million)
Table 77. Saudi Arabia Pet Diabetes Care Devices Market, by Animal Type, 2021-2031 (Revenue, $Million)
Table 78. Saudi Arabia Pet Diabetes Care Devices Market, by End-users, 2021-2031 (Revenue, $Million)
Table 79. South Africa Pet Diabetes Care Devices Market, by Device Type, 2021-2031 (Revenue, $Million)
Table 80. South Africa Pet Diabetes Care Devices Market, by Animal Type, 2021-2031 (Revenue, $Million)
Table 81. South Africa Pet Diabetes Care Devices Market, by End-users, 2021-2031 (Revenue, $Million)
Table 82. Rest of LAMEA Pet Diabetes Care Devices Market, by Device Type, 2021-2031 (Revenue, $Million)
Table 83. Rest of LAMEA Pet Diabetes Care Devices Market, by Animal Type, 2021-2031 (Revenue, $Million)
Table 84. Rest of LAMEA Pet Diabetes Care Devices Market, by End-users, 2021-2031 (Revenue, $Million)
Table 85. Allison Medical Inc.: Key Executives
Table 86. Allison Medical Inc.: Company Snapshot
Table 87. Allison Medical Inc.: Operating Segments
Table 88. Allison Medical Inc.: Product Portfolio
Table 89. Allison Medical Inc.: Net Sales
Table 90. Allison Medical Inc.: Key Stratergies
Table 91. Alr Technologies Inc.: Key Executives
Table 92. Alr Technologies Inc.: Company Snapshot
Table 93. Alr Technologies Inc.: Operating Segments
Table 94. Alr Technologies Inc.: Product Portfolio
Table 95. Alr Technologies Inc.: Net Sales
Table 96. Alr Technologies Inc.: Key Stratergies
Table 97. Med Trust LLC: Key Executives
Table 98. Med Trust LLC: Company Snapshot
Table 99. Med Trust LLC: Operating Segments
Table 100. Med Trust LLC: Product Portfolio
Table 101. Med Trust LLC: Net Sales
Table 102. Med Trust LLC: Key Stratergies
Table 103. Zoetis: Key Executives
Table 104. Zoetis: Company Snapshot
Table 105. Zoetis: Operating Segments
Table 106. Zoetis: Product Portfolio
Table 107. Zoetis: Net Sales
Table 108. Zoetis: Key Stratergies
Table 109. Accubiotech Co. Ltd.: Key Executives
Table 110. Accubiotech Co. Ltd.: Company Snapshot
Table 111. Accubiotech Co. Ltd.: Operating Segments
Table 112. Accubiotech Co. Ltd.: Product Portfolio
Table 113. Accubiotech Co. Ltd.: Net Sales
Table 114. Accubiotech Co. Ltd.: Key Stratergies
Table 115. Merck & Co. Inc.: Key Executives
Table 116. Merck & Co. Inc.: Company Snapshot
Table 117. Merck & Co. Inc.: Operating Segments
Table 118. Merck & Co. Inc.: Product Portfolio
Table 119. Merck & Co. Inc.: Net Sales
Table 120. Merck & Co. Inc.: Key Stratergies
Table 121. Becton, Dickinson and Company: Key Executives
Table 122. Becton, Dickinson and Company: Company Snapshot
Table 123. Becton, Dickinson and Company: Operating Segments
Table 124. Becton, Dickinson and Company: Product Portfolio
Table 125. Becton, Dickinson and Company: Net Sales
Table 126. Becton, Dickinson and Company: Key Stratergies
Table 127. Taidoc Technology Corp.: Key Executives
Table 128. Taidoc Technology Corp.: Company Snapshot
Table 129. Taidoc Technology Corp.: Operating Segments
Table 130. Taidoc Technology Corp.: Product Portfolio
Table 131. Taidoc Technology Corp.: Net Sales
Table 132. Taidoc Technology Corp.: Key Stratergies
Table 133. Ultimed, Inc: Key Executives
Table 134. Ultimed, Inc: Company Snapshot
Table 135. Ultimed, Inc: Operating Segments
Table 136. Ultimed, Inc: Product Portfolio
Table 137. Ultimed, Inc: Net Sales
Table 138. Ultimed, Inc: Key Stratergies
Table 139. I-Sens. Inc.: Key Executives
Table 140. I-Sens. Inc.: Company Snapshot
Table 141. I-Sens. Inc.: Operating Segments
Table 142. I-Sens. Inc.: Product Portfolio
Table 143. I-Sens. Inc.: Net Sales
Table 144. I-Sens. Inc.: Key Stratergies
List of Figures
Figure 1. Segmentation of Pet Diabetes Care Devices Market, 2021-2031
Figure 2. Pet Diabetes Care Devices Market, 2021-2031
Figure 3. Top Investment Pockets, by Region
Figure 4. Porter Five-1
Figure 5. Porter Five-2
Figure 6. Porter Five-3
Figure 7. Porter Five-4
Figure 8. Porter Five-5
Figure 9. Pet Diabetes Care Devices Market: Drivers, Restraints and Opportunities
Figure 10. Pet Diabetes Care Devices Market, by Device Type, 2021 (%)
Figure 11. Comparative Share Analysis of Glucose Monitoring Devices Pet Diabetes Care Devices Market, 2021 and 2031 (%)
Figure 12. Comparative Share Analysis of Insulin Delivery Devices Pet Diabetes Care Devices Market, 2021 and 2031 (%)
Figure 13. Pet Diabetes Care Devices Market, by Animal Type, 2021 (%)
Figure 14. Comparative Share Analysis of Dogs Pet Diabetes Care Devices Market, 2021 and 2031 (%)
Figure 15. Comparative Share Analysis of Cats Pet Diabetes Care Devices Market, 2021 and 2031 (%)
Figure 16. Pet Diabetes Care Devices Market, by End-users, 2021 (%)
Figure 17. Comparative Share Analysis of Homecare Pet Diabetes Care Devices Market, 2021 and 2031 (%)
Figure 18. Comparative Share Analysis of Veterinary Hospitals Pet Diabetes Care Devices Market, 2021 and 2031 (%)
Figure 19. Comparative Share Analysis of Others Pet Diabetes Care Devices Market, 2021 and 2031 (%)
Figure 20. Pet Diabetes Care Devices Market by Region, 2021
Figure 21. U.S. Pet Diabetes Care Devices Market, 2021-2031 ($Million)
Figure 22. Canada Pet Diabetes Care Devices Market, 2021-2031 ($Million)
Figure 23. Mexico Pet Diabetes Care Devices Market, 2021-2031 ($Million)
Figure 24. Germany Pet Diabetes Care Devices Market, 2021-2031 ($Million)
Figure 25. France Pet Diabetes Care Devices Market, 2021-2031 ($Million)
Figure 26. UK Pet Diabetes Care Devices Market, 2021-2031 ($Million)
Figure 27. Italy Pet Diabetes Care Devices Market, 2021-2031 ($Million)
Figure 28. Spain Pet Diabetes Care Devices Market, 2021-2031 ($Million)
Figure 29. Rest of Europe Pet Diabetes Care Devices Market, 2021-2031 ($Million)
Figure 30. China Pet Diabetes Care Devices Market, 2021-2031 ($Million)
Figure 31. Japan Pet Diabetes Care Devices Market, 2021-2031 ($Million)
Figure 32. India Pet Diabetes Care Devices Market, 2021-2031 ($Million)
Figure 33. Australia Pet Diabetes Care Devices Market, 2021-2031 ($Million)
Figure 34. South Korea Pet Diabetes Care Devices Market, 2021-2031 ($Million)
Figure 35. Rest of Asia-Pacific Pet Diabetes Care Devices Market, 2021-2031 ($Million)
Figure 36. Brazil Pet Diabetes Care Devices Market, 2021-2031 ($Million)
Figure 37. Saudi Arabia Pet Diabetes Care Devices Market, 2021-2031 ($Million)
Figure 38. South Africa Pet Diabetes Care Devices Market, 2021-2031 ($Million)
Figure 39. Rest of LAMEA Pet Diabetes Care Devices Market, 2021-2031 ($Million)
Figure 40. Top Winning Strategies, by Year
Figure 41. Top Winning Strategies, by Development
Figure 42. Top Winning Strategies, by Company
Figure 43. Product Mapping of Top 10 Players
Figure 44. Competitive Dashboard
Figure 45. Competitive Heatmap of Top 10 Key Players
Figure 46. Top Player Positioning, 2021
Figure 47. Allison Medical Inc..: Net Sales ($Million)
Figure 48. Alr Technologies Inc..: Net Sales ($Million)
Figure 49. Med Trust LLC.: Net Sales ($Million)
Figure 50. Zoetis.: Net Sales ($Million)
Figure 51. Accubiotech Co. Ltd..: Net Sales ($Million)
Figure 52. Merck & Co. Inc..: Net Sales ($Million)
Figure 53. Becton, Dickinson and Company.: Net Sales ($Million)
Figure 54. Taidoc Technology Corp..: Net Sales ($Million)
Figure 55. Ultimed, Inc.: Net Sales ($Million)
Figure 56. I-Sens. Inc..: Net Sales ($Million)
Executive Summary
According to the report titled, “Pet Diabetes Care Devices Market," The pet diabetes care devices market was valued at $1.9 billion in 2021, and is estimated to reach $3.5 billion by 2031, growing at a CAGR of 6.3% from 2022 to 2031.Diabetes mellitus is a condition that occurs when the body cannot use glucose normally. Glucose is the main source of energy for the body’s cells. Pets such as dogs and cats suffer from diabetes too. Obesity is a significant risk factor for development of diabetes in pets. The animals may also develop other diseases that can result in diabetes or can significantly affect their response to treatment for diabetes.
Key factors driving the growth of the pet diabetes care devices market include increase in prevalence of diabetes among dogs and cats, rise in the incidences of obesity, increase in demand for diabetes devices in the hospitals and increase in the technological advancements of the diabetes care devices. For instance, according to the data of International Journal of Current Microbiology and Applied Sciences that was published in 2021, the study was conducted to determine the incidence and record clinical manifestations in Jaipur (India), during June, 2020 to December, 2020. A total of two hundred canines of different age group, sex and breed with the history of polydipsia, polyphagia, polyuria, obesity, rapidly developing bilateral cataracts, rapid weight loss or in combination thereof were screened. The overall incidence of diabetes mellitus in canines was recorded 5.5%. Moreover, surge in number of pet owners and increase in the growth of veterinary medicine sector in developed and developing countries help boost the growth of the market. However, increase in costs of the medication is expected to hinder the growth of the market.
The market also offers growth opportunities to the key players in the market. The target population is in tremendous need of the devices in the region like Europe and Asia-Pacific. Hence, challenges to cater the unmet needs of the target population provides the growth opportunities. The online device delivery services have gained high traction in the last 4 years. As a result, engaged stakeholders in the industry have partnered with existing delivery services organization.
The global pet diabetes care devices market is segmented on the basis of device type, animal type, end user and region. On the basis of device type, the market is bifurcated into glucose monitoring devices and insulin delivery devices. On the basis of animal type, the market is classified into dogs and cats. On the basis of end user, the market is classified into homecare, veterinary hospitals and others. Region wise, the market is studied across North America (the U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
The key players profiled in the study include AccuBioTech Co., Ltd., Allison Medical Inc., ALR Technologies Inc., Becton, Dickinson and Company, MED Trust, Merck Animal Health, TaiDoc, UltiMed, Inc., Zoetis, i-SENS, Inc. The players in the market have been actively engaged in the adoption various strategies such as acquisition, product launch, and partnership to remain competitive and gain advantage over the competitors in the market. For instance, in June 2022, ALRT, announced the completion of a definitive manufacturing agreement with Infinovo Medical Co. Ltd. to manufacture and supply the Continuous Glucose Monitor (“CGM”) hardware that was utilized as a part of the ALRT GluCurve Pet CGM. This agreement gave ALRT the exclusive global rights to distribute the Infinovo CGM hardware for the animal health market, providing long-term production and supply.
Key Market Insights
- By device type, the insulin delivery devices segment was the highest revenue contributor to the market and is estimated to continue this during the analysis period, with a CAGR of 6.3%. However, the glucose monitoring devices segment is estimated to be the fastest-growing segment with a CAGR of 8.0% during the forecast period.
- By animal type, the cats segment dominated the global market. However, dogs segment is expected to be the fastest-growing segment with a CAGR of 6.8% during the forecast period.
- Based on end user, the veterinary hospitals segment was the highest revenue contributor to the market with a CAGR of 6.4% during the forecast period.
- Based on region, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR of 7.7% during the forecast period.
Companies Mentioned
- Allison Medical Inc.
- ALR Technologies Inc.
- Med Trust LLC
- Zoetis
- AccuBioTech Co., Ltd.
- Merck & Co. Inc.
- Becton, Dickinson and Company
- Taidoc Technology Corp.
- UltiMed, Inc
- I-SENS. Inc.
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 220 |
| Published | December 2022 |
| Forecast Period | 2021 - 2031 |
| Estimated Market Value ( USD | $ 1.9 billion |
| Forecasted Market Value ( USD | $ 3.5 billion |
| Compound Annual Growth Rate | 6.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
